China

RegistrationPost-marketClinical TrialMedical DeviceTestingChina AgentChina
Post-marketPost-market
+2+2
China PMS (Part 3): When Is Reassessment Needed?

China PMS (Part 3): When Is Reassessment Needed?

Elaine Tan
Post-marketPost-market
+2+2
Post-market Surveillance (Part 2)

Post-market Surveillance (Part 2)

Elaine Tan
Post-marketPost-market
+1+1
Post-market Surveillance (Part 1)

Post-market Surveillance (Part 1)

Elaine Tan
TestingTesting
+1+1
An Alternative to Accredited Laboratory Tests?

An Alternative to Accredited Laboratory Tests?

Elaine Tan
TestingTesting
+1+1
How to get your medical device tested in China

How to get your medical device tested in China

Elaine Tan
TestingTesting
+1+1
Your Blueprint to the Product Technical Requirements (PTR)

Your Blueprint to the Product Technical Requirements (PTR)

Elaine Tan
TestingTesting
+1+1
Mandatory or Recommended? Demystifying China’s Medical Device Standards

Mandatory or Recommended? Demystifying China’s Medical Device Standards

Elaine Tan
RegistrationRegistration
+1+1
Secure Made‐in‐China Approval by Moving Production to China

Secure Made‐in‐China Approval by Moving Production to China

Elaine Tan
Clinical TrialClinical Trial
+1+1
Clinical Evaluation Routes for Medical Devices in China

Clinical Evaluation Routes for Medical Devices in China

Elaine Tan
Clinical TrialClinical Trial
+2+2
Is Your Device Exempt from Clinical Evaluation?

Is Your Device Exempt from Clinical Evaluation?

Elaine Tan
Clinical TrialClinical Trial
+1+1
Entering the China Market: Clinical Trial vs Clinical Trial Exemption

Entering the China Market: Clinical Trial vs Clinical Trial Exemption

Elaine Tan
RegistrationRegistration
+1+1
Navigating the NMPA Registration Process: Timelines, Costs, and Considerations

Navigating the NMPA Registration Process: Timelines, Costs, and Considerations

Elaine Tan